Biocon Ltd. (BIOCON): Biocon Share Price rises 2.06% to Rs 381.75, market cap at Rs 62,091.35 crore
- September 17, 2026
- Posted by: Harsh Piplani
- Category: News
Biocon Share Price moved higher today as the stock rose 2.06% to Rs 381.75 from the previous close of Rs 374.05. The company’s market capitalisation stood at Rs 62,091.35 crore, placing Biocon in focus in today’s share market session. The day opened at Rs 374.7, touched a low of Rs 370.45 and reached the day’s high of Rs 381.75, which was also the last traded price in the supplied data. Turnover came in at Rs 1.87 crore. The available data confirms the price event, but it does not establish a company-specific catalyst. For investors scanning Biocon Share Price Today, the main question is how the move fits with valuation, sector positioning and financial ratios rather than a verified news trigger.
On Univest, Biocon Stock News can be tracked alongside the company’s share price update, market cap and peer context. The same-day share price rise is useful because it is observable, current and measurable, and it can be read together with the stock’s P/E of 123.07, P/B of 1.79, ROE of 1.35, ROCE of 3.26, EPS of 3.04, book value of Rs 208.53 and dividend yield of 0.13%.
Biocon Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 381.75 |
| Previous Close | Rs 374.05 |
| Today's Move | Rs 7.7 (+2.06%) |
| Open | Rs 374.7 |
| High | Rs 381.75 |
| Low | Rs 370.45 |
| Turnover | Rs 1.87 crore |
| Market Capitalisation | Rs 62,091.35 crore |
| Market Cap Category | Large Cap |
Biocon Ltd. (BIOCON) rose to Rs 381.75 from the previous close of Rs 374.05, a move of Rs 7.7 or 2.06%. The stock opened at Rs 374.7, reached a high of Rs 381.75, recorded a low of Rs 370.45.
Biocon Share Price Today reflects a same-day gain of Rs 7.7, or 2.06%, with the stock closing the session at Rs 381.75 after opening at Rs 374.7. The day range of Rs 370.45 to Rs 381.75 shows the price stayed within a relatively contained intraday band, and the close matched the day’s high. Compared with the previous close of Rs 374.05, the move was positive and clearly visible in today’s stock performance. The turnover of Rs 1.87 crore provides a factual traded-value reference for the session. In market terms, Biocon Stock Gaining Today is best described as a verified price rise rather than a move with a stated trigger. Biocon Share Price Live and Biocon Share Price Update are therefore being watched mainly for the numbers shown in the session data.
Biocon Ltd. (BIOCON) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 62,091.35 crore |
| P/E Ratio | 123.07x |
| P/B Ratio | 1.79x |
| ROE | 1.35% |
| ROCE | 3.26% |
| EPS | Rs 3.04 |
| Book Value Per Share | Rs 208.53 |
| Dividend Yield | 0.13% |
Biocon Ltd. (BIOCON) fundamental metrics show P/E 123.07x, P/B 1.79x, ROE 1.35%, ROCE 3.26%. These figures provide context only and are not a buy or sell signal.
Biocon Ltd. has a market capitalisation of Rs 62091.35 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 123.07x, P/B at 1.79x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 1.35% and ROCE of 3.26%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 3.04, book value per share of Rs 208.53, dividend yield of 0.13%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 31.35x, median ROE of 11.78%, median ROCE of 13.65%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 123.07x |
| Benchmark Median P/E | 31.35x |
| Benchmark Average P/E | 47.81x |
| Benchmark P/E Range | 3.45x to 661.74x |
| Company P/B Ratio | 1.79x |
| Benchmark Median P/B | 2.98x |
| Company ROE | 1.35% |
| Benchmark Median ROE | 11.78% |
| Company ROCE | 3.26% |
| Benchmark Median ROCE | 13.65% |
| Company Market Capitalisation | Rs 62,091.35 crore |
| Benchmark Median Market Cap | Rs 735.67 crore |
Biocon Ltd. (BIOCON) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Biocon Ltd. (BIOCON) has a P/E ratio of 123.07x, which is above the benchmark median of 31.35x, a difference of +292.57%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Biocon Ltd. (BIOCON) has a ROE of 1.35%, which is below the benchmark median of 11.78%, a difference of -88.54%. Biocon Ltd. (BIOCON) has a ROCE of 3.26%, which is below the benchmark median of 13.65%, a difference of -76.12%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,40,277.97 | 36.77 | 5.14 | 14.85 | 19.11 |
| Divi's Laboratories Ltd. | DIVISLAB | 2,43,965.63 | 83.5 | 13.83 | 16.19 | 21.51 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,84,478.41 | 84.11 | 20.44 | 26.76 | 19.27 |
| Cipla Ltd. | CIPLA | 1,09,949.53 | 32.59 | 3.12 | 11.83 | 16 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,09,625.67 | 24.42 | 4.09 | 19.69 | 21.39 |
Biocon Ltd. (BIOCON) has a P/E ratio of 123.07x compared with the displayed peer median of 36.77x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 1.35% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 3.26% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Biocon Ltd. (BIOCON) has a market capitalisation of Rs 62,091.35 crore. Among the 5 peers shown, 5 have a larger market capitalisation.
Why Investors Are Watching Biocon
- Biocon Share Price rose 2.06% today to Rs 381.75, which makes it a visible same-day mover in Biocon Stock News.
- The day range stayed between Rs 370.45 and Rs 381.75, and the close matched the session high.
- Biocon’s market cap stood at Rs 62,091.35 crore, and the company remains a large healthcare name by market value.
- The P/E ratio of 123.07 is above the same-industry median of 31.35 and average of 47.81.
- EPS of Rs 3.04, book value of Rs 208.53 and dividend yield of 0.13% provide further context for Biocon Fundamental Analysis.
About Biocon
Biocon Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The company is known for pharmaceutical business activities and sits among the better-known listed names in its field. In today’s market update, the relevant facts are its share price, market capitalisation and financial ratios rather than any fresh business announcement. Biocon Share News is therefore best understood through the lens of its operating segment, valuation and peer positioning.
For readers following Biocon Stock Performance, the supplied data shows a company with a substantial market cap, a low P/B relative to peers, and return ratios that are below the benchmark set. The company’s EPS of Rs 3.04 and book value of Rs 208.53 help anchor the basic financial picture, while dividend yield at 0.13% adds a payout reference. Univest tracks such company-level data so that Biocon Share Price can be viewed alongside its sector and financial backdrop.
Track Biocon Share Price on Univest
Use Biocon Ltd. (BIOCON) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
Investors can track Biocon Share Price on Univest for live share price updates, stock news, fundamental ratios, shareholding pattern, 52-week levels and market insights. Univest also helps readers compare Biocon Stock News with sector benchmarks, peer valuation and company financials in one place.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why did Biocon Share Price rise today?
Ans. Biocon Share Price rose 2.06% to Rs 381.75, but the supplied data does not establish a company-specific catalyst. The move is confirmed by the session’s price, open, high, low and turnover figures.
What is Biocon Share Price Today?
Ans. Biocon Share Price Today is Rs 381.75. It was up Rs 7.7 from the previous close of Rs 374.05, and the day’s high also matched Rs 381.75 in the supplied market data.
What is Biocon’s market capitalisation?
Ans. Biocon’s market capitalisation is Rs 62,091.35 crore. That places the company well above the same-industry median market cap of Rs 735.67 crore in the benchmark set used for comparison. The company operates in the Healthcare sector.
How does Biocon compare on valuation?
Ans. Biocon has a P/E of 123.07 and a P/B of 1.79. The P/E is above the same-industry median and average, while the P/B is below the benchmark median and average.
What do Biocon’s EPS and book value show?
Ans. Biocon’s EPS is Rs 3.04 and book value per share is Rs 208.53. EPS reflects earnings attributable to each share, while book value shows the accounting net worth behind each share.
How does Biocon stand against healthcare peers?
Ans. Biocon’s P/E of 123.07 is above Sun Pharma, Divi’s, Torrent, Cipla and Zydus Lifesciences in the supplied peer set. Its ROE and ROCE are also below all five peers listed.
